But the telehealth vendor’s new contract with the Defense Health Agency could support its path to profitability, management said.
Amwell reports widening net loss, including $79M impairment charge Read More »
An expected economic downturn has yet to materialize, leading Cigna to say Thursday it plans to add at least 1.6 million members this year, up from previous forecasts.
Cigna raises 2023 membership outlook amid healthier economy Read More »
The company paid $300 million to buy certain maternal fetal medicine and gynecological surgery products.
The massive for-profit operator has allegedly shuttered services at Mission Health, the hospital system it acquired in 2019, violating the terms of its purchase agreement.
Companies can make limited modifications on certain devices and manufacturing processes to address supply shortages or production limitations.
The company plans to use most of the $3.7 billion in after-tax proceeds from the biopharma solutions sale to repay debt.
Baxter completes biopharma solutions sale, business unit revamp Read More »
Neal Sample, first appointed in an adviser capacity in October, will report to CEO Tim Wentworth as EVP and CIO.
Walgreens appoints new CIO as leadership transition continues Read More »
The switch to virtual care has increased documentation burden for physicians, according to a new report published in JAMA.
Physicians spend more time after hours on EHR tasks post-COVID, report finds Read More »
La sostenibilidad y la eficiencia energética son fundamentales, de modo que la búsqueda de alternativas a los combustibles fósiles se ha convertido en una prioridad. Una de las soluciones más innovadoras y prometedoras en este ámbito es el coche que funciona con ai …
Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced a grant awarded by the Bill & Melinda Gates Foundation to support the tuberculosis (TB) test in development, designed to be run on the upcoming Co-Dx™ PCR platform*.
